USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ossur HF

USPTO PatentsView assignee record - 198 granted patents across 28 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ossur ranks #2,015 of 49,997 tracked US assignees by granted-patent volume, with 198 patents across 28 technology areas.

#2,015
of 49,997 US assignees by volume
Top 16%
by Innovation Score (48.8/100)
14.3
avg claims per patent
-63%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2015 · Foreign Corporation #2,015 · 198 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 198 grants
  • TOP-DECILE #2,015/49,997
  • PHOTO-FINISH CrossBar
  • CPC-FOCUS A61F · 28 areas
  • INNOV-PAR 48.8/100
  • CLAIMS-RICH 14.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -63% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: CrossBar, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ossur’s 48.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Ossur

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ossur's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Ossur?

Each dot is one of Ossur’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ossur’s own 14.3 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ossur vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 197.5198198.5199199.5 510152025 Granted patents (volume) Avg claims / patent Sorenson IP Holdings, LLC - 199, 13.99Sorenson IP Holdi…Valeo North America, Inc. - 199, 17Valeo North Ameri…CrossBar, Inc. - 198, 20.59CrossbarLagree Technologies, Inc. - 198, 21.81LagreePacific Market International, LLC - 198, 8.66Pacific Market In…Saint-gobain Abrasives, Inc. - 198, 17.99Saint-gobain Abra…Suntory Holdings Limited - 198, 8.96Suntory HoldingsState Grid Corporation of China - 198, 10.09State Grid of Chi…Ossur HF - 198, 14.28Ossur HF
Ossur vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ossur's grants concentrate

Ossur HF is a focused PatentsView assignee: 28 CPC subclasses with 93.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (37 grants) versus a trough of 4 in 2024. By volume, Ossur sits between Sorenson IP Holdings, LLC and State Grid Corporation of China.

Ossur's three-year grant acceleration

From 2019–2021 to 2022–2024, Ossur HF moved from 47 to 23 grants (0.49x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,719. See the growth leaderboard.

Who files at Ossur's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ossur holds 198 patents at rank #2,015, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ossur

By rank, the assignees closest to #2,015 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Ossur's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ossur, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Ossur ranks #32 of 3,082 assignees by patent count in that subclass.

Ossur's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 20152016201720182019202020212022202320242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Ossur HF patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 31 15.7%
2016 36 18.2%
2017 37 18.7%
2018 21 10.6%
2019 17 8.6%
2020 20 10.1%
2021 10 5.1%
2022 13 6.6%
2023 6 3.0%
2024 4 2.0%
2025partial year 3 1.5%

Which technologies does Ossur HF patent most?

Top 15 of 28 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Ossur HF's patent record in context - here's where to go next.

  • Ossur HF's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 93.9% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #2,015 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ossur HF against Sorenson IP Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.